Author:
Tomacinschii Victor,Mosquera Orgueira Adrian,Santos Carlos Aliste,Robu Maria,Buruiana Sanda,Fraga Rodriguez Maximo Francisco
Abstract
Next generation sequencing (NGS) is a technology that broadens the horizon of knowledge of several somatic pathologies, especially in oncological and oncohematological pathology. In the case of NHL, the understanding of the mechanisms of tumorigenesis, tumor proliferation and the identification of genetic markers specific to different lymphoma subtypes led to more accurate classification and diagnosis. Similarly, the data obtained through NGS allowed the identification of recurrent somatic mutations that can serve as therapeutic targets that can be inhibited and thus reducing the rate of resistant cases. The article’s purpose is to offer a comprehensive overview of the best ways of integrating of next-generation sequencing technologies for diagnosis, prognosis, classification, and selection of optimal therapy from the perspective of tailor-made medicine.
Reference123 articles.
1. Epidemiology of non-hodgkin’s lymphoma;Thandra;Med Sci,2021
2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021
3. Tumors of the hematopoietic system;Rappaport,1966
4. Cytological and functional criteria for the classification of Malignant lymphomata;Lennert;Br J Cancer,1975
5. Immunologic characterization of human Malignant lymphomas;Lukes;Cancer,1974